Piper Sandler Raises Quest Diagnostics (NYSE:DGX) Price Target to $165.00
MarketBeatPiper Sandler boosted their price target on Quest Diagnostics from $150.00 to $165.00 and gave the company a “neutral” rating in a report on Monday.
Piper Sandler boosted their price target on Quest Diagnostics from $150.00 to $165.00 and gave the company a “neutral” rating in a report on Monday.